蓝光动力疗法同步照射方案减轻光化性角化病疼痛的随机对照研究
该研究采用双侧对照、患者内设计,纳入23例患者,比较传统方案(ALA预孵育1小时后蓝光照射)与改良方案(ALA涂抹后立即开始蓝光照射)的疼痛与疗效。结果显示同步照射组疼痛显著低于传统组,治疗3个月后两侧病灶清除率几乎相同,非劣效性检验在±15%界值内成立。
要点
- 同步蓝光照射可显著减轻光动力疗法中的刺痛感
- 改良方案在3个月病灶清除率上与传统方案疗效相当
- 该方案为光化性角化病提供近乎无痛的治疗选择
核心结论
- 改良光动力疗法方案(ALA涂抹后立即开始蓝光照射)基本无痛,且疗效与传统方案相似。
研究设计与样本
- 双侧对照、患者内设计的临床试验,共纳入23例患者,面部和/或头皮涂抹20% ALA。
主要发现
- 所有患者在同步照射期间的疼痛均显著低于传统方案。
- 治疗3个月后,两侧病灶清除率几乎相同,非劣效性检验在±15%界值内成立。
关键数值与推荐
- 疼痛评估采用0至10分量表。
- 同步照射侧蓝光立即开始并持续30、45或60分钟;传统侧在ALA应用1小时后开始蓝光,持续1000秒。
- 病灶计数通过临床检查和摄影确定。
临床怎么用
- 临床可采用ALA涂抹后立即开始蓝光照射的同步方案,以减轻患者疼痛并维持疗效。
局限性
- 尽管为双侧对照设计,但研究样本量相对较小,建议进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Blue light photodynamic therapy (PDT) is effective for actinic keratosis, but many patients experience stinging pain during illumination. OBJECTIVE: To compare a conventional regimen (1 hour of 5-aminolevulinic acid [ALA] preincubation, followed by blue light) versus a new modified regimen in which blue light is started immediately after ALA application. METHODS: A clinical trial with a bilaterally controlled, intrapatient study design was conducted with 23 patients. Topical 20% ALA was applied to the entire face and/or scalp. On 1 side of the body, blue light was started immediately and continued for either 30, 45, or 60 minutes (simultaneous PDT). On the contralateral side, the blue light began 1 hour after ALA application and lasted 1000 seconds (conventional PDT). Pain was evaluated on a scale from 0 to 10. Actinic keratosis lesion counts were determined by clinical examination and photography. RESULTS: All patients experienced significantly less pain during simultaneous illumination than during the conventional regimen. At 3 months after treatment, lesion clearance was nearly identical on the 2 sides, as determined by statistical testing of noninferiority ± 15% margin. LIMITATIONS: Although bilaterally controlled, the study was relatively small. Additional studies are recommended. CONCLUSION: The modified PDT regimen is essentially painless, yet it provides treatment efficacy similar to a conventional regimen.
引用
- Kaw U, Ilyas M, Bullock T, et al. A regimen to minimize pain during blue light photodynamic therapy of actinic keratoses: Bilaterally controlled, randomized trial of simultaneous versus conventional illumination. J Am Acad Dermatol. 2019. PMID: 31525441. doi:10.1016/j.jaad.2019.09.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。